English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

WuXi Buys Antibody Maker Abgent

Oct. 13, 2011

On October 14, WuXi PharmaTech, a leading Chinese CRO, acquired Abgent, a provider of antibodies and custom services based in Suzhou and San Diego. Abgent brings to WuXi new product lines of biological research reagents for drug discovery and basic research to expand its service offering.